Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA

Microbial biofilms constitute a significant virulence factor and a substantial challenge in clinical environments due to their role in promoting antimicrobial resistance and their resilience to eradication efforts. Methicillin-resistant Staphylococcus aureus (MRSA) infections substantially increase...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Microbial pathogenesis 2024-12, Vol.197, p.107065, Article 107065
Hauptverfasser: Perini, Hugo Felix, Pereira, Bianca de Barros, Sousa, Eduarda Guimarães, Matos, Beatriz Sodré, Silva Prado, Ligia Carolina da, Carvalho Azevedo, Vasco Ariston de, Castro Soares, Siomar de, Silva, Marcos Vinicius da
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 107065
container_title Microbial pathogenesis
container_volume 197
creator Perini, Hugo Felix
Pereira, Bianca de Barros
Sousa, Eduarda Guimarães
Matos, Beatriz Sodré
Silva Prado, Ligia Carolina da
Carvalho Azevedo, Vasco Ariston de
Castro Soares, Siomar de
Silva, Marcos Vinicius da
description Microbial biofilms constitute a significant virulence factor and a substantial challenge in clinical environments due to their role in promoting antimicrobial resistance and their resilience to eradication efforts. Methicillin-resistant Staphylococcus aureus (MRSA) infections substantially increase healthcare costs, extend hospitalizations, and elevate morbidity and mortality rates. Therefore, developing innovative strategies to target and eliminate these bacteria and their biofilms effectively is imperative for robust epidemiological control. In this study, we evaluated the antibacterial and antibiofilm activities of cell-free supernatant (CFS) obtained from the Bacillus velezensis 1273 strain culture. Our data showed that CFS inhibited the growth of S. aureus ATCC 29213 and MRSA (clinical strain), with greater efficacy observed against S. aureus (1:16 dilution). Furthermore, CFS showed substantial potential in reducing biofilm formation in both strains (∼30 %) at subinhibitory concentrations. Additionally, the antibacterial activity against biofilm-formed cells showed that pure CFS treatment decreased the viability of S. aureus (60 %) and MRSA (45 %) sessile cells. We further demonstrated that CFS treatment induces the production of reactive oxygen species (ROS) and damages the membranes and cell walls of the pathogen cells. Genome analysis revealed the presence of genes encoding bacteriocins and secondary metabolites with antibacterial activity in the B. velezensis 1273 genome. These findings highlight the potential of probiotic bacterial metabolites as antibiofilm and anti-multidrug-resistant pathogens. [Display omitted] •B. velezensis 1273 showed metabolites with antibacterial properties in its genome.•The CFS of B. velezensis inhibits the biofilm formation of S. aureus and MRSA.•The CFS induces cell death in pre-formed biofilms of S. aureus and MRSA.•The cell-free supernatant causes bacterial cell damage through oxidative stress.
doi_str_mv 10.1016/j.micpath.2024.107065
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3120597255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0882401024005321</els_id><sourcerecordid>3120597255</sourcerecordid><originalsourceid>FETCH-LOGICAL-c243t-9d613fc49a2e8bfdaf001118269386314f1dd7af520a144d342b6f167a9c69283</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhS0EokPhEUBessngvzjxCpWqQKUiJApry7GvOx5l4mA7lYYH4XlxNANbVle6PsdH534IvaZkSwmV7_bbQ7CzKbstI0zUXUdk-wRtKFGyoYz0T9GG9D1rBKHkAr3IeU8IUYKr5-iCKyE6KfkG_b6ddmEIJaYjBu_BFhw9_mBsGMcl40cY4RdMOWRMWcdxLsmECVsYx8YnAJyXGdJkipkKNg_1LRfsoNriHKYHbCaH5wQ-pgM4PITow3jIa8R9MfPuOEYbra1BZkmwjqr_8u3-6iV65s2Y4dV5XqIfH2--X39u7r5-ur2-umssE7w0yknKvRXKMOgH74wnhFLaM6l4LzkVnjrXGd8yYqgQjgs2SE9lZ5SVivX8Er09_Tun-HOBXPQh5LWdmSAuWfN6yVZ1rG2rtD1JbYo51056TuFg0lFTolckeq_PSPSKRJ-QVN-bc8Qy1CP8c_1lUAXvTwKoRR8DJJ1tgMmCC6ny0C6G_0T8AV-XoYE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3120597255</pqid></control><display><type>article</type><title>Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Perini, Hugo Felix ; Pereira, Bianca de Barros ; Sousa, Eduarda Guimarães ; Matos, Beatriz Sodré ; Silva Prado, Ligia Carolina da ; Carvalho Azevedo, Vasco Ariston de ; Castro Soares, Siomar de ; Silva, Marcos Vinicius da</creator><creatorcontrib>Perini, Hugo Felix ; Pereira, Bianca de Barros ; Sousa, Eduarda Guimarães ; Matos, Beatriz Sodré ; Silva Prado, Ligia Carolina da ; Carvalho Azevedo, Vasco Ariston de ; Castro Soares, Siomar de ; Silva, Marcos Vinicius da</creatorcontrib><description>Microbial biofilms constitute a significant virulence factor and a substantial challenge in clinical environments due to their role in promoting antimicrobial resistance and their resilience to eradication efforts. Methicillin-resistant Staphylococcus aureus (MRSA) infections substantially increase healthcare costs, extend hospitalizations, and elevate morbidity and mortality rates. Therefore, developing innovative strategies to target and eliminate these bacteria and their biofilms effectively is imperative for robust epidemiological control. In this study, we evaluated the antibacterial and antibiofilm activities of cell-free supernatant (CFS) obtained from the Bacillus velezensis 1273 strain culture. Our data showed that CFS inhibited the growth of S. aureus ATCC 29213 and MRSA (clinical strain), with greater efficacy observed against S. aureus (1:16 dilution). Furthermore, CFS showed substantial potential in reducing biofilm formation in both strains (∼30 %) at subinhibitory concentrations. Additionally, the antibacterial activity against biofilm-formed cells showed that pure CFS treatment decreased the viability of S. aureus (60 %) and MRSA (45 %) sessile cells. We further demonstrated that CFS treatment induces the production of reactive oxygen species (ROS) and damages the membranes and cell walls of the pathogen cells. Genome analysis revealed the presence of genes encoding bacteriocins and secondary metabolites with antibacterial activity in the B. velezensis 1273 genome. These findings highlight the potential of probiotic bacterial metabolites as antibiofilm and anti-multidrug-resistant pathogens. [Display omitted] •B. velezensis 1273 showed metabolites with antibacterial properties in its genome.•The CFS of B. velezensis inhibits the biofilm formation of S. aureus and MRSA.•The CFS induces cell death in pre-formed biofilms of S. aureus and MRSA.•The cell-free supernatant causes bacterial cell damage through oxidative stress.</description><identifier>ISSN: 0882-4010</identifier><identifier>ISSN: 1096-1208</identifier><identifier>EISSN: 1096-1208</identifier><identifier>DOI: 10.1016/j.micpath.2024.107065</identifier><identifier>PMID: 39447663</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibacterial ; Antibiotic resistance ; Bacillus - genetics ; Bacillus - metabolism ; Bacillus - physiology ; Bacteriocins - metabolism ; Bacteriocins - pharmacology ; Biofilms - drug effects ; Biofilms - growth &amp; development ; Cell Wall - metabolism ; Methicillin-Resistant Staphylococcus aureus - drug effects ; Methicillin-Resistant Staphylococcus aureus - genetics ; Microbial Sensitivity Tests ; Microbial Viability - drug effects ; Pathogen ; Probiotic ; Reactive Oxygen Species - metabolism ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - genetics ; Staphylococcus aureus - physiology ; Virulence</subject><ispartof>Microbial pathogenesis, 2024-12, Vol.197, p.107065, Article 107065</ispartof><rights>2024 Elsevier Ltd</rights><rights>Copyright © 2024 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c243t-9d613fc49a2e8bfdaf001118269386314f1dd7af520a144d342b6f167a9c69283</cites><orcidid>0000-0003-1988-7273 ; 0000-0001-7299-3724 ; 0000-0001-8326-3612 ; 0009-0005-9227-3085</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.micpath.2024.107065$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39447663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perini, Hugo Felix</creatorcontrib><creatorcontrib>Pereira, Bianca de Barros</creatorcontrib><creatorcontrib>Sousa, Eduarda Guimarães</creatorcontrib><creatorcontrib>Matos, Beatriz Sodré</creatorcontrib><creatorcontrib>Silva Prado, Ligia Carolina da</creatorcontrib><creatorcontrib>Carvalho Azevedo, Vasco Ariston de</creatorcontrib><creatorcontrib>Castro Soares, Siomar de</creatorcontrib><creatorcontrib>Silva, Marcos Vinicius da</creatorcontrib><title>Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA</title><title>Microbial pathogenesis</title><addtitle>Microb Pathog</addtitle><description>Microbial biofilms constitute a significant virulence factor and a substantial challenge in clinical environments due to their role in promoting antimicrobial resistance and their resilience to eradication efforts. Methicillin-resistant Staphylococcus aureus (MRSA) infections substantially increase healthcare costs, extend hospitalizations, and elevate morbidity and mortality rates. Therefore, developing innovative strategies to target and eliminate these bacteria and their biofilms effectively is imperative for robust epidemiological control. In this study, we evaluated the antibacterial and antibiofilm activities of cell-free supernatant (CFS) obtained from the Bacillus velezensis 1273 strain culture. Our data showed that CFS inhibited the growth of S. aureus ATCC 29213 and MRSA (clinical strain), with greater efficacy observed against S. aureus (1:16 dilution). Furthermore, CFS showed substantial potential in reducing biofilm formation in both strains (∼30 %) at subinhibitory concentrations. Additionally, the antibacterial activity against biofilm-formed cells showed that pure CFS treatment decreased the viability of S. aureus (60 %) and MRSA (45 %) sessile cells. We further demonstrated that CFS treatment induces the production of reactive oxygen species (ROS) and damages the membranes and cell walls of the pathogen cells. Genome analysis revealed the presence of genes encoding bacteriocins and secondary metabolites with antibacterial activity in the B. velezensis 1273 genome. These findings highlight the potential of probiotic bacterial metabolites as antibiofilm and anti-multidrug-resistant pathogens. [Display omitted] •B. velezensis 1273 showed metabolites with antibacterial properties in its genome.•The CFS of B. velezensis inhibits the biofilm formation of S. aureus and MRSA.•The CFS induces cell death in pre-formed biofilms of S. aureus and MRSA.•The cell-free supernatant causes bacterial cell damage through oxidative stress.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial</subject><subject>Antibiotic resistance</subject><subject>Bacillus - genetics</subject><subject>Bacillus - metabolism</subject><subject>Bacillus - physiology</subject><subject>Bacteriocins - metabolism</subject><subject>Bacteriocins - pharmacology</subject><subject>Biofilms - drug effects</subject><subject>Biofilms - growth &amp; development</subject><subject>Cell Wall - metabolism</subject><subject>Methicillin-Resistant Staphylococcus aureus - drug effects</subject><subject>Methicillin-Resistant Staphylococcus aureus - genetics</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbial Viability - drug effects</subject><subject>Pathogen</subject><subject>Probiotic</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - genetics</subject><subject>Staphylococcus aureus - physiology</subject><subject>Virulence</subject><issn>0882-4010</issn><issn>1096-1208</issn><issn>1096-1208</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhS0EokPhEUBessngvzjxCpWqQKUiJApry7GvOx5l4mA7lYYH4XlxNANbVle6PsdH534IvaZkSwmV7_bbQ7CzKbstI0zUXUdk-wRtKFGyoYz0T9GG9D1rBKHkAr3IeU8IUYKr5-iCKyE6KfkG_b6ddmEIJaYjBu_BFhw9_mBsGMcl40cY4RdMOWRMWcdxLsmECVsYx8YnAJyXGdJkipkKNg_1LRfsoNriHKYHbCaH5wQ-pgM4PITow3jIa8R9MfPuOEYbra1BZkmwjqr_8u3-6iV65s2Y4dV5XqIfH2--X39u7r5-ur2-umssE7w0yknKvRXKMOgH74wnhFLaM6l4LzkVnjrXGd8yYqgQjgs2SE9lZ5SVivX8Er09_Tun-HOBXPQh5LWdmSAuWfN6yVZ1rG2rtD1JbYo51056TuFg0lFTolckeq_PSPSKRJ-QVN-bc8Qy1CP8c_1lUAXvTwKoRR8DJJ1tgMmCC6ny0C6G_0T8AV-XoYE</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Perini, Hugo Felix</creator><creator>Pereira, Bianca de Barros</creator><creator>Sousa, Eduarda Guimarães</creator><creator>Matos, Beatriz Sodré</creator><creator>Silva Prado, Ligia Carolina da</creator><creator>Carvalho Azevedo, Vasco Ariston de</creator><creator>Castro Soares, Siomar de</creator><creator>Silva, Marcos Vinicius da</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1988-7273</orcidid><orcidid>https://orcid.org/0000-0001-7299-3724</orcidid><orcidid>https://orcid.org/0000-0001-8326-3612</orcidid><orcidid>https://orcid.org/0009-0005-9227-3085</orcidid></search><sort><creationdate>202412</creationdate><title>Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA</title><author>Perini, Hugo Felix ; Pereira, Bianca de Barros ; Sousa, Eduarda Guimarães ; Matos, Beatriz Sodré ; Silva Prado, Ligia Carolina da ; Carvalho Azevedo, Vasco Ariston de ; Castro Soares, Siomar de ; Silva, Marcos Vinicius da</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c243t-9d613fc49a2e8bfdaf001118269386314f1dd7af520a144d342b6f167a9c69283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial</topic><topic>Antibiotic resistance</topic><topic>Bacillus - genetics</topic><topic>Bacillus - metabolism</topic><topic>Bacillus - physiology</topic><topic>Bacteriocins - metabolism</topic><topic>Bacteriocins - pharmacology</topic><topic>Biofilms - drug effects</topic><topic>Biofilms - growth &amp; development</topic><topic>Cell Wall - metabolism</topic><topic>Methicillin-Resistant Staphylococcus aureus - drug effects</topic><topic>Methicillin-Resistant Staphylococcus aureus - genetics</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbial Viability - drug effects</topic><topic>Pathogen</topic><topic>Probiotic</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - genetics</topic><topic>Staphylococcus aureus - physiology</topic><topic>Virulence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perini, Hugo Felix</creatorcontrib><creatorcontrib>Pereira, Bianca de Barros</creatorcontrib><creatorcontrib>Sousa, Eduarda Guimarães</creatorcontrib><creatorcontrib>Matos, Beatriz Sodré</creatorcontrib><creatorcontrib>Silva Prado, Ligia Carolina da</creatorcontrib><creatorcontrib>Carvalho Azevedo, Vasco Ariston de</creatorcontrib><creatorcontrib>Castro Soares, Siomar de</creatorcontrib><creatorcontrib>Silva, Marcos Vinicius da</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Microbial pathogenesis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perini, Hugo Felix</au><au>Pereira, Bianca de Barros</au><au>Sousa, Eduarda Guimarães</au><au>Matos, Beatriz Sodré</au><au>Silva Prado, Ligia Carolina da</au><au>Carvalho Azevedo, Vasco Ariston de</au><au>Castro Soares, Siomar de</au><au>Silva, Marcos Vinicius da</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA</atitle><jtitle>Microbial pathogenesis</jtitle><addtitle>Microb Pathog</addtitle><date>2024-12</date><risdate>2024</risdate><volume>197</volume><spage>107065</spage><pages>107065-</pages><artnum>107065</artnum><issn>0882-4010</issn><issn>1096-1208</issn><eissn>1096-1208</eissn><abstract>Microbial biofilms constitute a significant virulence factor and a substantial challenge in clinical environments due to their role in promoting antimicrobial resistance and their resilience to eradication efforts. Methicillin-resistant Staphylococcus aureus (MRSA) infections substantially increase healthcare costs, extend hospitalizations, and elevate morbidity and mortality rates. Therefore, developing innovative strategies to target and eliminate these bacteria and their biofilms effectively is imperative for robust epidemiological control. In this study, we evaluated the antibacterial and antibiofilm activities of cell-free supernatant (CFS) obtained from the Bacillus velezensis 1273 strain culture. Our data showed that CFS inhibited the growth of S. aureus ATCC 29213 and MRSA (clinical strain), with greater efficacy observed against S. aureus (1:16 dilution). Furthermore, CFS showed substantial potential in reducing biofilm formation in both strains (∼30 %) at subinhibitory concentrations. Additionally, the antibacterial activity against biofilm-formed cells showed that pure CFS treatment decreased the viability of S. aureus (60 %) and MRSA (45 %) sessile cells. We further demonstrated that CFS treatment induces the production of reactive oxygen species (ROS) and damages the membranes and cell walls of the pathogen cells. Genome analysis revealed the presence of genes encoding bacteriocins and secondary metabolites with antibacterial activity in the B. velezensis 1273 genome. These findings highlight the potential of probiotic bacterial metabolites as antibiofilm and anti-multidrug-resistant pathogens. [Display omitted] •B. velezensis 1273 showed metabolites with antibacterial properties in its genome.•The CFS of B. velezensis inhibits the biofilm formation of S. aureus and MRSA.•The CFS induces cell death in pre-formed biofilms of S. aureus and MRSA.•The cell-free supernatant causes bacterial cell damage through oxidative stress.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>39447663</pmid><doi>10.1016/j.micpath.2024.107065</doi><orcidid>https://orcid.org/0000-0003-1988-7273</orcidid><orcidid>https://orcid.org/0000-0001-7299-3724</orcidid><orcidid>https://orcid.org/0000-0001-8326-3612</orcidid><orcidid>https://orcid.org/0009-0005-9227-3085</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0882-4010
ispartof Microbial pathogenesis, 2024-12, Vol.197, p.107065, Article 107065
issn 0882-4010
1096-1208
1096-1208
language eng
recordid cdi_proquest_miscellaneous_3120597255
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Anti-Bacterial Agents - pharmacology
Antibacterial
Antibiotic resistance
Bacillus - genetics
Bacillus - metabolism
Bacillus - physiology
Bacteriocins - metabolism
Bacteriocins - pharmacology
Biofilms - drug effects
Biofilms - growth & development
Cell Wall - metabolism
Methicillin-Resistant Staphylococcus aureus - drug effects
Methicillin-Resistant Staphylococcus aureus - genetics
Microbial Sensitivity Tests
Microbial Viability - drug effects
Pathogen
Probiotic
Reactive Oxygen Species - metabolism
Staphylococcus aureus - drug effects
Staphylococcus aureus - genetics
Staphylococcus aureus - physiology
Virulence
title Inhibitory effect of Bacillus velezensis 1273 strain cell-free supernatant against developing and preformed biofilms of Staphylococcus aureus and MRSA
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T21%3A41%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibitory%20effect%20of%20Bacillus%20velezensis%201273%20strain%20cell-free%20supernatant%20against%20developing%20and%20preformed%20biofilms%20of%20Staphylococcus%20aureus%20and%20MRSA&rft.jtitle=Microbial%20pathogenesis&rft.au=Perini,%20Hugo%20Felix&rft.date=2024-12&rft.volume=197&rft.spage=107065&rft.pages=107065-&rft.artnum=107065&rft.issn=0882-4010&rft.eissn=1096-1208&rft_id=info:doi/10.1016/j.micpath.2024.107065&rft_dat=%3Cproquest_cross%3E3120597255%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3120597255&rft_id=info:pmid/39447663&rft_els_id=S0882401024005321&rfr_iscdi=true